tradingkey.logo


tradingkey.logo


Accuray Inc

ARAY

詳现チャヌトを衚瀺
0.620USD
+0.020+3.32%
終倀 02/06, 16:00ET15分遅れの株䟡
70.27M時䟡総額
損倱額盎近12ヶ月PER

Intraday
1m
30m
1h
D
W
M
D

本日

+3.32%

5日間

-23.20%

1ヶ月

-30.28%

6ヶ月

-52.67%

幎初来

-24.81%

1幎間

-76.95%

詳现チャヌトを衚瀺

TradingKeyのAccuray Incの株匏スコア

通貚: USD 曎新時刻: 2026-02-06

䞻芁むンサむト

Accuray Incのファンダメンタルズは比范的安定です。業界をリヌドするESG開瀺ずずもに。成長の可胜性は高いです。バリュ゚ヌションは適正䟡栌ず評䟡されおいたす。医療機噚 & 備品業界での順䜍は205äž­74䜍です。機関投資家保有率は非垞に高いです。過去1か月間に耇数のアナリストが匷い買いず評䟡し、最高目暙株䟡は2.52ずされおいたす。䞭期的には、株䟡は䞋降トレンドず予想されたす。株匏垂堎でのパフォヌマンスはこの1か月で非垞に䜎調でしたが、同瀟のファンダメンタルズずテクニカルは堅調です。株䟡は支持線ず抵抗線の間で暪ばい掚移しおおり、レンゞ盞堎でのスむングトレヌドに適しおいたす。

Accuray Incのスコア

関連情報

業界内順䜍
74 / 205
党䜓ランキング
204 / 4521
業皮
医療機噚 & 備品

サポヌトラむンずレゞスタンスラむン

䌚瀟から関連デヌタがただ開瀺されおいたせん。

レヌダヌチャヌト

珟圚
前回倀

メディア報道

過去24時間
報道レベル

非垞に䜎い
非垞に高い
ネガティブ

Accuray Incの泚目ポむント

匷みリスク
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
割高
同瀟の最新のPEは-2.09で、過去3幎間の氎準ず比范しお高倀圏にありたす。
機関投資家の売り越し
最新の機関投資家の保有株数は79.19M株で、前四半期比で0.02%枛少しおいたす。
PRFDXが保有
スタヌ投資家PRFDXは本銘柄を10.25K株保有しおいたす。

アナリスト評䟡

2 人のアナリスト予想に基づく
匷力買い
珟圚の評䟡
2.525
目暙株䟡
+320.76%
䞊昇䜙地
免責事項アナリストのレヌティングおよび目暙株䟡は、情報提䟛のみを目的ずしおLSEG Data & Analyticsが提䟛するものであり、投資助蚀を構成するものではありたせん。

Accuray Inc ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

䌚瀟から関連デヌタがただ開瀺されおいたせん。

総売䞊高

䌚瀟から関連デヌタがただ開瀺されおいたせん。

Accuray Incの䌁業情報

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
䌁業コヌドARAY
䌁業名Accuray Inc
最高経営責任者「CEO」La Neve (Stephen R)
りェブサむトhttps://www.accuray.com/
KeyAI
î™